Table of Content


1. Introduction



2. Research & Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global Next Generation Sequencing Market



6. Market Share
6.1 By Product
6.2 By Application
6.3 By Technology
6.4 By End User
6.5 By Countries


7. Product
7.1 Instruments
7.2 Reagents & Consumables
7.3 Services


8. Application
8.1 Diagnostics
8.2 Agriculture and Animal Research
8.3 Drug Discovery
8.4 Personalized Medicine and Genetic Screening
8.5 Others


9. Technology
9.1 Sequencing by Synthesis
9.2 Ion Semiconductor Sequencing
9.3 Single Molecule Read Time Sequencing
9.4 Nanopore Sequencing
9.5 Others


10. End User
10.1 Academic and Clinical Research Centers
10.2 Pharmaceutical and Biotechnology Companies
10.3 Hospitals and Clinics
10.4 Others


11. Countries
11.1 North America

11.1.1 United States
11.1.2 Canada

11.2 Europe

11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherlands
11.2.8 Turkey

11.3 Asia Pacific

11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand

11.4 Latin America

11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina

11.5 Middle East & Africa

11.5.1 Saudi Arabia
11.5.2 United Arab Emirates
11.5.3 South Africa


12. Porter’s Five Forces Analysis
12.1 Threat of New Entry
12.2 The Bargaining Power of Buyer
12.3 Threat of Substitution
12.4 The Bargaining Power of Supplier
12.5 Competitive Rivalry


13. SWOT Analysis
13.1 Strengths
13.2 Weaknesses
13.3 Opportunities
13.4 Threats


14. Key Players Analysis
14.1 Illumina

14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue

14.2 Thermo Fisher Scientific

14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue

14.3 Pacific Biosciences

14.3.1 Overview
14.3.2 Recent Development
14.3.3 Revenue

14.4 QIAGEN N.V

14.4.1 Overview
14.4.2 Recent Development
14.4.3 Revenue

14.5 Roche

14.5.1 Overview
14.5.2 Recent Development
14.5.3 Revenue

14.6 Bio-Rad Laboratories, Inc.

14.6.1 Overview
14.6.2 Recent Development
14.6.3 Revenue

14.7 Takara Bio Inc

14.7.1 Overview
14.7.2 Recent Development
14.7.3 Revenue

14.8 Hamilton Company

14.8.1 Overview
14.8.2 Recent Development
14.8.3 Revenue

14.9 Geneious

14.9.1 Overview
14.9.2 Recent Development
14.9.3 Revenue

14.10 BioM?rieux SA

14.10.1 Overview
14.10.2 Recent Development
14.10.3 Revenue



List of Figures


0

List of Tables


0